| 1. |
Pisters KM, Le Chevalier T. Adjuvant chemotherapy in completely resected non-small-cell lung cancer. J Clin Oncol, 2005, 23(14): 3270-3278.
|
| 2. |
Burdett S, Stewart L, Auperin A, et al. Chemotherapy in non small cell lung cancer: an update of an individual patient data meta analysis. J Clin Oncol, 2005, 23(4): 924-926.
|
| 3. |
Pataer A, Kalhor N, Correa AM, et al. Histopathologic response criteria predict survival of patients with resected lung cancer after neoadjuvant chemotherapy. J Thorac Oncol, 2012, 7(5): 825-832.
|
| 4. |
Cascone T, Gold KA, Swisher SG, et al. Induction cisplatin docetaxel followed by surgery and erlotinib in non- small cell lung cancer. Ann Thorac Surg, 2018, 105(2): 418-424.
|
| 5. |
Provencio-Pulla M, Nadal-Alforja E, Cobo M, et al. Neoadjuvant chemo /immunotherapy for the treatment of stages ⅢA resectable non-small cell lung cancer (NSCLC): A phase Ⅱ multicenter exploratory study—NADIM study-SLCG. J Clin Oncol, 2018, 36(15): 8521.
|
| 6. |
Shu C, Grigg C, Chiuzan C, et al. Neoadjuvant atezolizumab + chemotherapy in resectable non-small cell lung cancer (NSCLC). J Clin Oncol, 2018, 36: 8532.
|
| 7. |
Kayawake H, Okumura N, Yamanashi K, et al. Non-small cell lung cancer with pathological complete response: predictive factors and surgical outcomes. Gen Thorac Cardiovasc Surg, 2019, 67: 773-781.
|
| 8. |
Westeel V, Quoix E, Puyraveau M, et al. A randomised trial comparing preoperative to perioperative chemotherapy in early-stage non-small-cell lung cancer (IFCT0002 trial). Eur J Cancer, 2013, 49(12): 2654-2664.
|
| 9. |
NSCLC Meta-analysis Collaborative Group. Preoperative chemotherapy for non-small-cell lung cancer: a systematic review and meta-analysis of individual participant data. Lancet, 2014, 383(9928): 1561-1571.
|
| 10. |
Smithy JW, Rosen JE, Gao SJ, et al. Postneoadjuvant adjuvant chemotherapy in resected N1 non-small cell lung cancer with residual nodal disease. J Surg Oncol, 2017, 116(8): 1193-1196.
|
| 11. |
Mouillet G, Monnet E, Milleron B, et al. Pathologic complete response to preoperative chemotherapy predicts cure in early-stage non-small-cell lung cancer: combined analysis of two IFCT randomized trials. J Thorac Oncol, 2012, 7(5): 841-849.
|
1/5
WeChat